NIH-funded research U01 cooperative agreement

Ending Tobacco Use with a smartphone program for Cambodians living with HIV

Official title: Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)

Funded at H. Lee Moffitt Cancer Ctr & Res Inst · NIH-11413458 · Data updated 2026-11-12

A smartphone-based, tailored smoking-cessation program for people living with HIV in Cambodia is being tested to help them quit smoking.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionH. Lee Moffitt Cancer Ctr & Res Inst
NIH-funded
Lab location1 site (Tampa, United States)
Project startSeptember 17, 2021
Project endAugust 31, 2027
Funding year2026
Award (this year)$398,198
NIH project number5U01CA261598-06
Project IDNIH-11413458 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV/AIDS in Cambodia who use smartphones and are seeking to quit smoking.

Less likely to help

People without HIV or those who do not use smartphones may not benefit from this intervention.

What this research studies

This project tests a fully automated mobile intervention combined with medicine and behavioral support to help Cambodian people living with HIV quit smoking. It uses interactive messages tailored to the individual and delivered through smartphones, aiming to be low-cost and scalable. The study is a randomized trial conducted in Cambodia to see if this approach improves quitting rates and HIV care outcomes. Results could inform practical smoking-cessation options for people with HIV in resource-limited settings.

Why it matters

Potential benefit: If successful, the program could reduce smoking-related health risks and improve HIV care for people living with HIV in Cambodia and similar settings.

How similar studies have gone: Previous mHealth smoking-cessation studies show promise but evidence in people with HIV in low-resource settings is still emerging.

Where this research is happening

  • H. Lee Moffitt Cancer Ctr & Res Inst
    Tampa, United States
    Active

Researchers

  • Principal investigator: Vidrine, Damon J. — H. Lee Moffitt Cancer Ctr & Res Inst
  • Study coordinator: Vidrine, Damon J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.